Close Menu

NEW YORK – Kroger Health has partnered with Myriad Genetics to launch a pilot program involving the GeneSight pharmacogenetic test for personalizing depression treatments.

Within this pilot, 500 Kroger pharmacies in five states will provide information about GeneSight PGx testing to members who have failed one or more antidepressant treatments. These members will receive information about testing through their pharmacists or in the mail. Those interested will be directed to speak to their healthcare provider to determining if testing is appropriate.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Pfizer and BioNTech announce they are seeking FDA authorization for their candidate SARS-CoV-2 vaccine.

Science has retracted a 2007 paper from a former Dutch minister and his colleagues, according to Retraction Watch.

The New York Times reports that a plan to cull minks in Denmark to prevent the spread of a new SARS-CoV-2 strain led to calls for the prime minister's resignation.

In Science this week: winner of the Science & SciLifeLab Prize for Young Scientists, and more.

Dec
03
Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.